MARKET

ELMD

ELMD

ELECTROMED
AMEX

Real-time Quotes | Nasdaq Last Sale

11.97
-0.14
-1.16%
After Hours: 11.97 0 0.00% 16:00 03/05 EST
OPEN
12.11
PREV CLOSE
12.11
HIGH
12.11
LOW
11.51
VOLUME
60.17K
TURNOVER
--
52 WEEK HIGH
19.73
52 WEEK LOW
6.92
MARKET CAP
103.36M
P/E (TTM)
28.98
1D
5D
1M
3M
1Y
5Y
Electromed, Inc. to Participate in the Sidoti Spring 2021 Virtual Investor Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen...
BusinessWire - BZX · 3d ago
DJ Electromed, Inc. CEO Kathleen Skarvan on Q2 2021 Results -- Earnings Call Transcript >ELMD
Dow Jones · 02/10 02:29
Electromed, Inc. (ELMD) Q2 Earnings and Revenues Top Estimates
Zacks.com · 02/09 22:25
BRIEF-Electromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results
reuters.com · 02/09 21:41
Electromed EPS beats by $0.09, beats on revenue
Electromed (ELMD): FQ2 GAAP EPS of $0.13 beats by $0.09.Revenue of $9.5M (+11.1% Y/Y) beats by $1.36M.The Company’s balance sheet at Dec. 31, 2020 included cash of $11.7M, accounts receivable
Seekingalpha · 02/09 21:38
10-Q: ELECTROMED, INC.
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. The following discussion and...
Edgar Online - (EDG = 10Q, 10K) · 02/09 21:23
Electromed Q2 EPS $0.13 Beats $0.04 Estimate, Sales $9.50M Beat $8.14M Estimate
Electromed (AMEX:ELMD) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.04 by 225 percent. This is a 7.14 percent decrease over earnings of $0.14 per share from the same
Benzinga · 02/09 21:21
Electromed 2Q Rev $9.5M >ELMD
Electromed 2Q Rev $9.5M >ELMD
Dow Jones · 02/09 21:09
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ELMD. Analyze the recent business situations of ELECTROMED through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ELMD stock price target is 18.00 with a high estimate of 21.00 and a low estimate of 15.00.
EPS
Institutional Holdings
Institutions: 23
Institutional Holdings: 2.17M
% Owned: 25.17%
Shares Outstanding: 8.64M
TypeInstitutionsShares
Increased
5
98.26K
New
2
23.76K
Decreased
5
33.16K
Sold Out
4
31.21K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.35%
Healthcare Equipment & Supplies
+2.13%
Key Executives
Chairman/Director
Stephen Craney
President/Chief Executive Officer/Director
Kathleen Skarvan
Chief Financial Officer
Michael MacCourt
Independent Director
Stan Erickson
Independent Director
Gregory Fluet
Independent Director
Lee Jones
Independent Director
Andrea Walsh
Independent Director
George Winn
No Data
About ELMD
Electromed, Inc. develops, manufactures and markets airway clearance products, which apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The Company's products include the SmartVest Airway Clearance System (SmartVest System), the SmartVest SQL System and others. As of June 30, 2016, the SmartVest System is available in two models: SV2100 and SQL. The SmartVest System consists of an inflatable therapy garment, a programmable air pulse generator and a single-hose, which delivers air pulses from the generator to the garment. The SmartVest SQL System is small, quiet and light, and offers generator programmability. The Company markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to healthcare providers, particularly those working in intensive care units. The Company sells its products to the home healthcare market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis and neuromuscular disease.

Webull offers kinds of Electromed, Inc. stock information, including AMEX:ELMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ELMD stock methods without spending real money on the virtual paper trading platform.